Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment?

Creative Commons License

Sütcüoğlu O., Yazıcı O., Özet A.

Future oncology (London, England), cilt.17, ss.4823-4825, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 17
  • Basım Tarihi: 2021
  • Doi Numarası: 10.2217/fon-2021-1107
  • Dergi Adı: Future oncology (London, England)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.4823-4825
  • Anahtar Kelimeler: breast cancer, hormonal therapy, hypertriglyceridemia, side effects, tamoxifen, RANDOMIZED-TRIAL, INDUCED HYPERTRIGLYCERIDEMIA, ACUTE-PANCREATITIS, BREAST, WOMEN, PROLIFERATION, THERAPY, MARKERS
  • Gazi Üniversitesi Adresli: Evet